Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.
Press releases published on May 7, 2025
Generation Bio Reports Recent Business Highlights and First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
- Company continues to advance its strategy to develop first-in-class treatments for T cell-driven autoimmune diseases using its cell-targeted lipid nanoparticle (ctLNP) technology to deliver siRNA - Lead target and portfolio strategy to be announced mid …
Astera Labs to Participate in the J.P. Morgan 53rd Annual Global Technology, Media, and Communications Conference
GlobeNewswire
·
May 7, 2025
SANTA CLARA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Astera Labs (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced that it will participate in the J.P. Morgan 53rd Annual Global …
Akero Therapeutics to Present at the BofA Securities 2025 Healthcare Conference
GlobeNewswire
·
May 7, 2025
SOUTH SAN FRANCISCO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today …
HeartCore to Present at Sidoti Micro-Cap Virtual Conference on May 21, 2025 at 11:30 a.m. ET
GlobeNewswire
·
May 7, 2025
NEW YORK and TOKYO, May 07, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company based in Tokyo, will be virtually presenting and holding one- …
Aardvark Therapeutics to Present at Upcoming Investor Conferences in May
GlobeNewswire
·
May 7, 2025
SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment …
RxSight, Inc. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 7, 2025
ALISO VIEJO, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for …
TTM Technologies, Inc. Launches Five New High-Performance Radio Frequency Components to Meet the Growing Demands in Telecom, Test and Measurement, and COTS Mil-Aero Applications
GlobeNewswire
·
May 7, 2025
SANTA ANA, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI) (“TTM”), a leading global manufacturer of technology solutions including mission systems, radio frequency (“RF”) components and RF microwave/microelectronic …
Century Aluminum Company Reports First Quarter 2025 Results
GlobeNewswire
·
May 7, 2025
CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its first quarter 2025 results. First Quarter 2025 Financial Results $MM (except shipments and per share data) Q1 2025 Q4 2024 Aluminum shipments ( …
Q3 2025 Results: Lesaka delivers on guidance, reaffirms FY2025 outlook and projects positive net income in FY2026
GlobeNewswire
·
May 7, 2025
JOHANNESBURG, May 07, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the third quarter of fiscal 2025 (“Q3 2025”). Q3 2025 performance: Revenue of $135.7 million (ZAR 2.5 billion) was at the midpoint …
Texas Capital Announces Expansion of Corporate and Investment Banking Division
GlobeNewswire
·
May 7, 2025
DALLAS, May 07, 2025 (GLOBE NEWSWIRE) -- Texas Capital Securities, a subsidiary of Texas Capital Bancshares, Inc. (NASDAQ: TCBI), today announced a significant expansion of the services offered by its Corporate and Investment Bank. The additions to …
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 7, 2025
Interim Data from Low Dose Cohort in MyPEAKTM-1 Clinical Trial of TN-201 Showed Encouraging Safety Profile, Transduction and Expression, Plus Improvements in Hypertrophy and NYHA Classification RIDGE Natural History and Seroprevalence Study Highlights …
LumenHaus präsentiert kundenzentrierte KI-Lösungen für das Zuhause auf der Smarter E 2025
GlobeNewswire
·
May 7, 2025
MÜNCHEN, May 07, 2025 (GLOBE NEWSWIRE) -- LumenHaus, ein innovativer Anbieter von Energielösungen für den Haushalt, hat auf der Smarter E Europe 2025 seine kundenzentrierten KI-Lösungen vorgestellt. Besucher konnten eintauchen in die Welt eines …
Redefining Smart Living: LumenHaus Showcases Human-Centered AI Home Energy Solutions at The Smarter E 2025
GlobeNewswire
·
May 7, 2025
MUNICH, May 07, 2025 (GLOBE NEWSWIRE) -- LumenHaus, an innovative provider of household energy solutions, presented its human-centric AI solutions at Smarter E Europe 2025. Visitors were able to immerse themselves in the world of a sustainable energy …
Clarisil Pro Under Review: Proven Hearing Loss Support Supplement with Secret Navajo Remedy
GlobeNewswire
·
May 7, 2025
New York, May 07, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why hearing loss is on the rise—and how environmental and lifestyle factors play a major role The most common causes of auditory decline, including inflammation, nutritional …
Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress
GlobeNewswire
·
May 7, 2025
Strong execution of two ongoing Phase 3 trials of daraxonrasib; company expects to substantially complete enrollment of RASolute 302 in patients with pancreatic cancer this year New non-small cell lung cancer clinical data from RAS(ON) inhibitor portfolio …
Duolingo to Participate in JP Morgan’s Annual Global Technology, Media and Communications Conference
GlobeNewswire
·
May 7, 2025
PITTSBURGH, May 07, 2025 (GLOBE NEWSWIRE) -- Duolingo, Inc. (Nasdaq: DUOL) announced that Matthew Skaruppa, CFO, will host a fireside chat at the JP Morgan’s Annual Global Technology, Media and Communications Conference on May 13, 2025 at 4:30 p.m. EDT. A …
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
GlobeNewswire
·
May 7, 2025
BURLINGTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management …
Anika to Participate in the Sidoti Virtual Investor Conference
GlobeNewswire
·
May 7, 2025
BEDFORD, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that …
New Toll Brothers Copperhaven Model Home Opens in West Jordan, Utah
GlobeNewswire
·
May 7, 2025
WEST JORDAN, Utah, May 07, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL) the nation’s leading builder of luxury homes, today announced the grand opening of the new model home at its Copperhaven by Toll Brothers community located in the heart of …
FormFactor Announces Participation at Upcoming Conferences
GlobeNewswire
·
May 7, 2025
LIVERMORE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the following investor conferences: B. Riley 25th Annual Investor Conference Location: The Ritz-Carlton, Marina del Rey Date: …